Form D · Biotechnology
NANOMR, INC.
Albuquerque, NM · CIK 0001439419
Offering snapshot reported Dec 20, 2013 · SEC filing
- Reported sold
- $2.4M Offering amount: $2.4M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 17, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 20, 2013 | Initial | $2,400,000 | No comparison | 3 | SEC filing |
| Jul 9, 2013 | Initial | $2,623,512 | No comparison | 3 | SEC filing |
| Jul 22, 2011 | Initial | $11,430,685 | No comparison | 8 | SEC filing |
| Nov 10, 2010 | Initial | $2,000,000 | No comparison | 3 | SEC filing |
| Jul 2, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-208520
Source: Form D, filed Dec 20, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gavin Christensen | Director |
| Sally Corning | Director |
| Lisa Dunlea | Director |
| Victor Esch | Director, Executive |
| Steven Gullans | Director |
| Steve C, Gullans | Director |
| Augustine Lawlor | Director |
| Caroline Popper | Director |
| Waneta C. Tuttle | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5741 Midway Park Blvd.
Albuquerque, NM, 87109
Albuquerque, NM, 87109